Farabi Pharmaceutical (XTEH:DFRB1) Receivables Turnover: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Farabi Pharmaceutical Receivables Turnover?

Farabi Pharmaceutical XTEH:DFRB1 Receivables Turnover is 0.00 as of . 20.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's average Accounts Receivable for the three months ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical  (XTEH:DFRB1) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Farabi Pharmaceutical Receivables Turnover Related Terms

Farabi Pharmaceutical Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Receivables Turnover Chart

Farabi Pharmaceutical Annual Data
Trend
Receivables Turnover

Farabi Pharmaceutical Quarterly Data
Receivables Turnover

XTEH:DFRB1 vs IMNPQ, INNV: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Receivables Turnover falls into.


Farabi Pharmaceutical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Farabi Pharmaceutical's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

Receivables Turnover (A: . 20 )
=Revenue / Average Accounts Receivable
=Revenue (A: . 20 ) / ((Accounts Receivable (A: . 20 ) + Accounts Receivable (A: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

Farabi Pharmaceutical's Receivables Turnover for the quarter that ended in . 20 is calculated as

Receivables Turnover (Q: . 20 )
=Revenue / Average Accounts Receivable
=Revenue (Q: . 20 ) / ((Accounts Receivable (Q: . 20 ) + Accounts Receivable (Q: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Receivables Turnover of 0.00 as of . 20. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Receivables Turnover too high?
Farabi Pharmaceutical's current Receivables Turnover is 0.00.
How does Farabi Pharmaceutical's Receivables Turnover compare to IMNPQ and INNV?
Farabi Pharmaceutical's Receivables Turnover of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Receivables Turnover is 5.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.06, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Receivables Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.